Theseus Pharmaceuticals, Inc.
THRX
Cena:
Valuace
70
Růst
0
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 2.1 mil | 4.84% | 0.06% | 0.46% | 2022-12-31 |
| LYNX1 CAPITAL MANAGEMENT LP | 702.42 tis | 1.60% | -0.13% | 1.12% | 2021-12-31 |
| 174.72 tis | 0.40% | 0.25% | 0.25% | 2023-12-31 | |
| ADAR1 CAPITAL MANAGEMENT, LLC | 174.72 tis | 0.40% | 0.25% | 0.25% | 2023-12-31 |
| VIRTU FINANCIAL LLC | 26.47 tis | 0.06% | 0.01% | 0.01% | 2023-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-12-31 |
| PRINCIPAL FINANCIAL GROUP INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-06-30 |
| RHUMBLINE ADVISERS | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| ORBIMED ADVISORS LLC | 0.00 tis | 0.00% | -1.44% | 0.00% | 2021-12-31 |
| OMEGA FUND MANAGEMENT, LLC | 0.00 tis | 0.00% | -2.33% | 0.00% | 2021-12-31 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| NORTHERN TRUST CORP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| MORGAN STANLEY | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| MMCAP INTERNATIONAL INC. SPC | 0.00 tis | 0.00% | -0.21% | 0.00% | 2023-12-31 |
| LEGAL & GENERAL GROUP PLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| LAURION CAPITAL MANAGEMENT LP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| RONALD BLUE TRUST, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| ROYAL BANK OF CANADA | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| WELLS FARGO & COMPANY/MN | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-03-31 |
| WALLEYE CAPITAL LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-06-30 |
| VANGUARD GROUP INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| UBS OCONNOR LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-03-31 |
| UBS GROUP AG | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-12-31 |
| TWO SIGMA INVESTMENTS, LP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-12-31 |
| TWO SIGMA ADVISERS, LP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-03-31 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| TANG CAPITAL MANAGEMENT LLC | 0.00 tis | 0.00% | -1.22% | 0.00% | 2023-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| STRS OHIO | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| STATE STREET CORP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| SQUAREPOINT OPS LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| SG AMERICAS SECURITIES, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| JPMORGAN CHASE & CO | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| JBF CAPITAL, INC. | 0.00 tis | 0.00% | -0.02% | 0.00% | 2023-12-31 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.00 tis | 0.00% | -0.01% | 0.00% | 2023-12-31 |
| BML CAPITAL MANAGEMENT, LLC | 0.00 tis | 0.00% | -3.27% | 0.00% | 2023-12-31 |
| BLACKROCK INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| BERYL CAPITAL MANAGEMENT LLC | 0.00 tis | 0.00% | -0.64% | 0.00% | 2023-12-31 |
| BARCLAYS PLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-03-31 |
| BANK OF NEW YORK MELLON CORP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| BANK OF AMERICA CORP /DE/ | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| AMERICAN INTERNATIONAL GROUP, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| AMERICAN CENTURY COMPANIES INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| AMALGAMATED BANK | 0.00 tis | 0.00% | 0.00% | 0.00% | 2022-03-31 |
| ALLIANCEBERNSTEIN L.P. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-03-31 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| CITADEL ADVISORS LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| CITIGROUP INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0.00 tis | 0.00% | -0.10% | 0.00% | 2023-12-31 |
| GOLDMAN SACHS GROUP INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-06-30 |
| GLASSMAN WEALTH SERVICES | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| FORESITE CAPITAL MANAGEMENT V, LLC | 0.00 tis | 0.00% | -22.67% | 0.00% | 2021-12-31 |
| FMR LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| FIFTH LANE CAPITAL, LP | 0.00 tis | 0.00% | -0.12% | 0.00% | 2023-12-31 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.00 tis | 0.00% | -0.01% | 0.00% | 2023-06-30 |
| EVERSOURCE WEALTH ADVISORS, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| ENSIGN PEAK ADVISORS, INC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| DIMENSIONAL FUND ADVISORS LP | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-06-30 |
| DEUTSCHE BANK AG\ | 0.00 tis | 0.00% | 0.00% | 0.00% | 2021-12-31 |
| DENALI ADVISORS LLC | 0.00 tis | 0.00% | -0.13% | 0.00% | 2023-06-30 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-12-31 |
| ACADIAN ASSET MANAGEMENT LLC | 0.00 tis | 0.00% | 0.00% | 0.00% | 2023-09-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Dahms Bradford D. | officer: President and CFO | D-Return | 332114 | 4.03 | 14.2 2024 | 0 |
| Dahms Bradford D. | officer: President and CFO | U-Tender | 8150 | 4.05 | 14.2 2024 | 0 |
| Dahms Bradford D. | officer: President and CFO | D-Return | 17500 | 0.00 | 14.2 2024 | 0 |
| Dukes Iain D. | director | D-Return | 344344 | 0.32 | 14.2 2024 | 0 |
| Dukes Iain D. | director | D-Return | 3250 | 0.00 | 14.2 2024 | 0 |
| Dukes Iain D. | director | D-Return | 61549 | 4.03 | 14.2 2024 | 0 |
| Dukes Iain D. | director | U-Tender | 388324 | 4.05 | 14.2 2024 | 0 |
| GORDON CARL L | director, 10 percent owner: | D-Return | 3250 | 0.00 | 14.2 2024 | 0 |
| GORDON CARL L | director, 10 percent owner: | U-Tender | 650600 | 4.05 | 14.2 2024 | 0 |
| HAYDEN DONALD J JR | director | D-Return | 3250 | 0.00 | 14.2 2024 | 0 |
| HAYDEN DONALD J JR | director | U-Tender | 10000 | 4.05 | 14.2 2024 | 0 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | U-Tender | 650600 | 4.05 | 14.2 2024 | 0 |
| Stein Steven H | director | D-Return | 3250 | 0.00 | 14.2 2024 | 0 |
| Yi Kathy | director | D-Return | 99634 | 4.03 | 14.2 2024 | 0 |
| Yi Kathy | director | D-Return | 3250 | 0.00 | 14.2 2024 | 0 |
| Shakespeare William | officer: See Remarks | M-Exempt | 251084 | 0.32 | 7.11 2023 | 93260 |
| Shakespeare William | officer: See Remarks | M-Exempt | 251084 | 0.32 | 7.11 2023 | 639408 |
| Foresite Capital Management V, LLC | 10 percent owner | P-Purchase | 176550 | 2.97 | 19.7 2023 | 1385825 |
| Foresite Capital Management V, LLC | 10 percent owner | P-Purchase | 523450 | 2.97 | 19.7 2023 | 4108796 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | 151450 | 3.05 | 19.7 2023 | 650600 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | 328482 | 3.05 | 19.7 2023 | 17063000 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 151450 | 3.05 | 19.7 2023 | 650600 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 328482 | 3.05 | 19.7 2023 | 17063000 |
| Dukes Iain D. | director | A-Award | 3250 | 0.00 | 13.6 2023 | 3250 |
| Dukes Iain D. | director | A-Award | 19500 | 9.61 | 13.6 2023 | 19500 |
| GORDON CARL L | director, 10 percent owner: | A-Award | 3250 | 0.00 | 13.6 2023 | 3250 |
| GORDON CARL L | director, 10 percent owner: | A-Award | 19500 | 9.61 | 13.6 2023 | 19500 |
| HAYDEN DONALD J JR | director | A-Award | 3250 | 0.00 | 13.6 2023 | 3250 |
| HAYDEN DONALD J JR | director | A-Award | 19500 | 9.61 | 13.6 2023 | 19500 |
| Yi Kathy | director | A-Award | 3250 | 0.00 | 13.6 2023 | 3250 |
| Yi Kathy | director | A-Award | 19500 | 9.61 | 13.6 2023 | 19500 |
| Stein Steven H | director | A-Award | 3250 | 0.00 | 13.6 2023 | 3250 |
| Stein Steven H | director | A-Award | 19500 | 9.61 | 13.6 2023 | 19500 |
| CLACKSON TIMOTHY P | director, officer: President and CEO | A-Award | 45625 | 0.00 | 2.3 2023 | 45625 |
| Dahms Bradford D. | officer: Chief Financial Officer | A-Award | 17500 | 0.00 | 2.3 2023 | 17500 |
| Kerstein David | officer: Chief Medical Officer | A-Award | 17500 | 0.00 | 2.3 2023 | 17500 |
| Shakespeare William | officer: See Remarks | A-Award | 21250 | 0.00 | 2.3 2023 | 21250 |
| Rivera Victor | officer: Chief Scientific Officer | A-Award | 16250 | 0.00 | 2.3 2023 | 16250 |
| CLACKSON TIMOTHY P | director, officer: President and CEO | A-Award | 273750 | 11.42 | 21.2 2023 | 273750 |
| Dahms Bradford D. | officer: Chief Financial Officer | A-Award | 105000 | 11.42 | 21.2 2023 | 105000 |
| Kerstein David | officer: Chief Medical Officer | A-Award | 105000 | 11.42 | 21.2 2023 | 105000 |
| Rivera Victor | officer: Chief Scientific Officer | A-Award | 97500 | 11.42 | 21.2 2023 | 97500 |
| Shakespeare William | officer: See Remarks | A-Award | 127500 | 11.42 | 21.2 2023 | 127500 |
| HAYDEN DONALD J JR | director | P-Purchase | 100 | 5.00 | 3.1 2023 | 100 |
| HAYDEN DONALD J JR | director | P-Purchase | 9900 | 5.00 | 3.1 2023 | 10000 |
| Foresite Capital Management V, LLC | director | P-Purchase | 250000 | 5.00 | 3.1 2023 | 1209275 |
| Foresite Capital Management V, LLC | director | P-Purchase | 250000 | 5.00 | 3.1 2023 | 3585346 |
| Dahms Bradford D. | officer: Chief Financial Officer | P-Purchase | 1502 | 6.66 | 1.12 2022 | 6142 |
| CLACKSON TIMOTHY P | officer: President and CEO | P-Purchase | 2500 | 6.80 | 14.11 2022 | 351030 |
| ORBIMED ADVISORS LLC | director | P-Purchase | 192000 | 5.21 | 9.11 2022 | 16734518 |
| GORDON CARL L | director | P-Purchase | 192000 | 5.21 | 9.11 2022 | 16734518 |
| Stein Steven H | 0.00 | 19.10 2022 | 0 | |||
| Stein Steven H | director: | 0 | 0.00 | 19.10 2022 | 0 | |
| Stein Steven H | director | A-Award | 60000 | 0.00 | 19.10 2022 | 60000 |
| Foresite Capital Management V, LLC | director | 0 | 0.00 | 13.6 2022 | 959275 | |
| Foresite Capital Management V, LLC | director | 0 | 0.00 | 13.6 2022 | 3335346 | |
| GORDON CARL L | director: | A-Award | 30000 | 0.00 | 13.6 2022 | 30000 |
| GORDON CARL L | director, 10 percent owner: | A-Award | 30000 | 5.75 | 13.6 2022 | 30000 |
| Dukes Iain D. | director, officer: Chairman | A-Award | 15000 | 5.75 | 13.6 2022 | 15000 |
| Dukes Iain D. | officer: Chairman | A-Award | 15000 | 0.00 | 13.6 2022 | 15000 |
| Dukes Iain D. | director, officer: Chairman | A-Award | 30000 | 5.75 | 13.6 2022 | 30000 |
| Yi Kathy | director: | A-Award | 30000 | 0.00 | 13.6 2022 | 30000 |
| HAYDEN DONALD J JR | director: | 0 | 0.00 | 18.5 2022 | 0 | |
| HAYDEN DONALD J JR | director: | A-Award | 60000 | 0.00 | 18.5 2022 | 60000 |
| HAYDEN DONALD J JR | director | A-Award | 60000 | 8.02 | 18.5 2022 | 60000 |
| Rivera Victor | officer: Chief Scientific Officer | A-Award | 130000 | 11.21 | 23.2 2022 | 130000 |
| Shakespeare William | officer: See Remarks | A-Award | 180000 | 11.21 | 23.2 2022 | 180000 |
| Dahms Bradford D. | officer: Chief Financial Officer | A-Award | 150000 | 11.21 | 23.2 2022 | 150000 |
| Dalgarno David | officer: Chief Technical Officer | A-Award | 130000 | 11.21 | 23.2 2022 | 130000 |
| CLACKSON TIMOTHY P | director, officer: President and CEO | A-Award | 450000 | 11.21 | 23.2 2022 | 450000 |
| Kerstein David | officer: Chief Medical Officer | A-Award | 150000 | 11.21 | 23.2 2022 | 150000 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | 11521 | 9.97 | 21.1 2022 | 16395756 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | 35000 | 9.95 | 21.1 2022 | 16430756 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | 111896 | 9.97 | 21.1 2022 | 16542652 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 11521 | 9.97 | 21.1 2022 | 16395756 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 35000 | 9.95 | 21.1 2022 | 16430756 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 111896 | 9.97 | 21.1 2022 | 16542652 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | 1600 | 9.81 | 13.1 2022 | 16341118 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | 6900 | 10.67 | 13.1 2022 | 16348018 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | 18897 | 10.06 | 13.1 2022 | 16366915 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | 17320 | 9.43 | 13.1 2022 | 16384235 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 1600 | 9.81 | 13.1 2022 | 16341118 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 6900 | 10.67 | 13.1 2022 | 16348018 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 18897 | 10.06 | 13.1 2022 | 16366915 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 17320 | 9.43 | 13.1 2022 | 16384235 |
| Dahms Bradford D. | officer: Chief Financial Officer | P-Purchase | 1970 | 10.15 | 22.12 2021 | 1970 |
| CLACKSON TIMOTHY P | director, officer: President and CEO | P-Purchase | 2600 | 9.76 | 22.12 2021 | 348530 |
| TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 1615427 | 0.00 | 15.10 2021 | 0 | |
| TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | C-Conversi | 1615427 | 0.00 | 15.10 2021 | 0 |
| TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | C-Conversi | 1615427 | 0.00 | 15.10 2021 | 1615427 |
| Rock Springs Capital Management LP | 10 percent owner | C-Conversi | 87329 | 0.00 | 14.10 2021 | 87329 |
| Rock Springs Capital Management LP | 10 percent owner | C-Conversi | 349320 | 0.00 | 14.10 2021 | 349320 |
| Rock Springs Capital Management LP | 10 percent owner | P-Purchase | 250000 | 16.00 | 14.10 2021 | 599320 |
| Shakespeare William | officer: See Remarks | P-Purchase | 625 | 16.00 | 14.10 2021 | 388949 |
| GORDON CARL L | director, 10 percent owner: | C-Conversi | 14903718 | 0.00 | 14.10 2021 | 0 |
| GORDON CARL L | director, 10 percent owner: | C-Conversi | 436650 | 0.00 | 14.10 2021 | 0 |
| GORDON CARL L | director, 10 percent owner: | C-Conversi | 436650 | 0.00 | 14.10 2021 | 436650 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 62500 | 16.00 | 14.10 2021 | 499150 |
| GORDON CARL L | director, 10 percent owner: | C-Conversi | 15777018 | 0.00 | 14.10 2021 | 15777018 |
| GORDON CARL L | director, 10 percent owner: | P-Purchase | 562500 | 16.00 | 14.10 2021 | 16339518 |
